Responding to a critical global need

As the global prevalence of diabetes and other chronic conditions continues to rise, the need for innovative glucose monitoring approaches is growing. Individuals living with diabetes are increasingly seeking better solutions for everyday life.

Glucotrack is investigating a novel approach called continuous blood glucose monitoring intended to address limitations associated with current standards. For investors focused on healthcare innovation, Glucotrack represents an opportunity to participate in advancing research in diabetes technology.

Investor resources

Events & Presentations

Glucotrack December 2025 Investor Presentation

Title

Download

All Access TV Interview – March 2025 – Paul V. Goode, PhD, President and CEO

Glucotrack’s CBGM Technology – January 2025 – Mark Tapsak, PhD, Vice President of Sensor Technology

First Patient Enrolled – December 2024 – Paul V. Goode, PhD, President and CEO

Does the Market Really Need Another Continuous Glucose Monitor – December 2024 – Drinda Benjamin, Vice President of Marketing

Glucotrack Overview – October 2024 – Paul V. Goode, PhD, President and CEO

Sidoti Small Cap Conference, June 2024 – Paul V. Goode, PhD, President and CEO

Sidoti Small Cap Conference, June 2024 – Paul V. Goode, PhD, President and CEO

Emerging Growth Conference, April 2024 – Mark Tapsak, PhD, VP of Sensor Technology

Emerging Growth Conference, January 2024 – Paul V. Goode, PhD, President and CEO

SEC Filings

Governance Documents

Title

Download

Code of Ethics

Whistleblower Policy

Nominating and Corporate Governance Committee Charter

Audit Committee Charter

Compensation Committee Charter